Jan 14, 2020
Phagenesis Receives FDA Breakthrough Device Designation for Its Phagenyx® System to Accelerate Removal of the Breathing Tube by Treating Neurogenic Dysphagia
Aug 26, 2019
ARKRAY USA Launches Phazix Pill Swallowing Gel
Aug 26, 2019
FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea
Aug 05, 2019
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® THIN LIQUID (barium sulfate) for oral suspension
Jun 19, 2019
Bracco Diagnostics Inc. Acknowledges Speech Language Pathologists during June - National Dysphagia Awareness Month
Feb 28, 2019
ITF Pharma Receives Patient Impact Award for First and Only Easy-To-Swallow Thickened Liquid Treatment for Amyotrophic Lateral Sclerosis (ALS)
Jan 21, 2019
ARKRAY USA Launches Assure® Slide Swallowing Aid
Nov 26, 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Nov 13, 2018
NYU Winthrop's Advances in Detecting and Treating Preterm Infant Feeding Problems Are Expected to Prompt Paradigm Shift in Protocol Across U.S., Improving Neonatal Outcomes and Reducing Medical Expenses
Sep 04, 2018
Multicentre Randomised Controlled Trial Confirms the Significant Benefits of Phagenyx® Treatment for Tracheostomised Stroke Patients With Dysphagia
May 09, 2018
Biohaven Initiates Expanded Access Program for Sublingual BHV-0223 ZYDIS® Orally Dissolving Tablets for Patients with Amyotrophic Lateral Sclerosis (ALS)
Apr 24, 2018
ASX/NASDAQ Announcement
Nov 06, 2017
Optim LLC Showcases ENTity(TM) Stroboscopy at Nation's Largest Speech Pathology Conference
Jul 28, 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® NECTAR (barium sulfate) Oral Suspension